​

The ambitions of CCCC for the 4 core focus areas.​

Our aim is that all patients with a cancer disease should have the opportunity to be included in a research protocol in the CCCC. 

Our clinical research portfolio for studies with antineoplastic treatment should span broadly from early phase 1 trials to clinical studies in phase 2 and 3. Research within all aspects of cancer treatment and care will be prioritized, which will furthermore include trials in radiotherapy, genomic sequencing, personalized medicine, nurse-led studies, palliative medicine/care, rehabilitation, late effects after treatment, cancer-survivorship, etc.

The accreditation of CCCC improves our European and International networks and these collaboration opportunities will allow us to attract additional and greater research grants to the center.